Arrhythmias. Cardiac resynchronization therapy in women
- PMID: 25072912
- DOI: 10.1038/nrcardio.2014.113
Arrhythmias. Cardiac resynchronization therapy in women
Abstract
A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a shorter QRS duration than men. Recognizing these sex-specific differences is important to improve outcomes for women with HF.
Comment on
-
Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.JAMA Intern Med. 2014 Aug;174(8):1340-8. doi: 10.1001/jamainternmed.2014.2717. JAMA Intern Med. 2014. PMID: 25090172
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
